BIO Asia–Taiwan 2025 亞洲生技大會

BIO Asia–Taiwan 2025 亞洲生技大會

講師

Bobby Sheng

​​

Session 8 – Strategic Insights into CMC Program Design:
Pioneering Biologics Development Excellence

Date:25 July (Thursday)
Time12:25 – 12:30 (GMT+8)

Bobby Sheng

Chairman & CEO
​​
Bora Biologics Co., Ltd.

​​

Bobby Sheng is the CEO and Chairman of the Bora Group, which owns 8 companies, including Bora Biologics. He first founded Bora Pharmaceuticals in 2007, took it to public offering in 2017 and has subsequently led Bora Pharmaceuticals to become Taiwan’s largest exporter of Pharmaceuticals to over 100 countries. Through successful acquisitions, Bora is currently the only CDMO in Taiwan that has a leading position in both small and large molecules with 7 manufacturing sites with over 60 Billion NTD market cap.
A California native and an experienced leader in the pharmaceutical industry, Bobby is also a serial entrepreneur.  His previous successes include bringing Keihl’s to Taiwan and co-founding the music label Machi.  Bobby has also been involved in multiple successful start-up companies in the IT and Entertainment Industry.  He is skilled in International Business, Management, Mergers & Acquisitions (M&A), Finance, and Marketing and graduated with a Bachelor’s Degree from University of California, Berkeley.

Speech title & Synopsis

Opening Remarks

.

​​